Details of the Drug Combinations

General Information of This Drug (ID: DMAH59S)

Drug Name
Amonafide   DMAH59S
Synonyms Quinamed (TN)
Indication
Disease Entry ICD 11 Status REF
Breast cancer 2C60-2C65 Phase 3 [1]
Ovarian cancer 2C73 Phase 3 [1]
Prostate cancer 2C82.0 Phase 3 [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

636 Investigative Drug Combination(s) Consisting of This drug
Normalized Drug Combination Synergy Score
Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.
DrugCom Name DrugCom ID Component Drug Indication REF
ABIRATERONE + Amonafide DCTIBIN ABIRATERONE Astrocytoma (Cell Line: SNB-19) [2]
ABIRATERONE + Amonafide DCVF2O6 ABIRATERONE Clear cell renal cell carcinoma (Cell Line: 786-0) [2]
ABIRATERONE + Amonafide DC53XKB ABIRATERONE Carcinoma (Cell Line: MCF7) [3]
ABIRATERONE + Amonafide DCYN3JC ABIRATERONE Adenocarcinoma (Cell Line: HT29) [4]
Amonafide + Mechlorethamine DCFUMKZ Mechlorethamine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
Amonafide + Mechlorethamine DCCZ5OK Mechlorethamine Malignant melanoma (Cell Line: LOX IMVI) [2]
Amonafide + Pentostatin DCJ7M0D Pentostatin Clear cell renal cell carcinoma (Cell Line: 786-0) [2]
Amonafide + Fulvestrant DCASZ89 Fulvestrant Adenocarcinoma (Cell Line: DU-145) [2]
Amonafide + Fulvestrant DCA8HHZ Fulvestrant Adenocarcinoma (Cell Line: HCC-2998) [2]
Amonafide + Fulvestrant DC4VM2A Fulvestrant Chronic myelogenous leukemia (Cell Line: K-562) [2]
Amonafide + Ruxolitinib DCUTW0G Ruxolitinib Hodgkin lymphoma (Cell Line: L-1236) [2]
Amonafide + Hepzato DC8B38X Hepzato Adenocarcinoma (Cell Line: HCT116) [2]
Amonafide + Hepzato DC8E8SR Hepzato Chronic myelogenous leukemia (Cell Line: K-562) [2]
Amonafide + Ixabepilone DCN2UHD Ixabepilone Adenocarcinoma (Cell Line: DU-145) [2]
Amonafide + Ixabepilone DCI84K8 Ixabepilone Adenocarcinoma (Cell Line: A549) [2]
Amonafide + Ixabepilone DC9MQQL Ixabepilone Adenocarcinoma (Cell Line: HCT-15) [2]
Amonafide + Ixabepilone DCZ7ZGQ Ixabepilone Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
Amonafide + Ixabepilone DCK9R9T Ixabepilone Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Amonafide + Ixabepilone DCCLHA8 Ixabepilone Amelanotic melanoma (Cell Line: M14) [2]
Amonafide + Ixabepilone DC8V8OK Ixabepilone Astrocytoma (Cell Line: U251) [2]
Amonafide + Ixabepilone DCJ7ZSV Ixabepilone Astrocytoma (Cell Line: SNB-19) [2]
Amonafide + Ixabepilone DC6LHDX Ixabepilone Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [2]
Amonafide + Ixabepilone DCZRZ1C Ixabepilone Glioma (Cell Line: SF-295) [2]
Amonafide + Ixabepilone DCY13QG Ixabepilone Malignant melanoma (Cell Line: UACC62) [2]
Amonafide + Ixabepilone DCT1CR6 Ixabepilone Malignant melanoma (Cell Line: LOX IMVI) [2]
Amonafide + Ixabepilone DCFEH7X Ixabepilone Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [2]
Amonafide + Dactinomycin DCVG6LV Dactinomycin Adenocarcinoma (Cell Line: DU-145) [2]
Amonafide + Dactinomycin DCAN4GX Dactinomycin Adenocarcinoma (Cell Line: NCIH23) [2]
Amonafide + Dactinomycin DC8TA0U Dactinomycin Adenocarcinoma (Cell Line: SW-620) [2]
Amonafide + Dactinomycin DCQ10N9 Dactinomycin Adenocarcinoma (Cell Line: HCT116) [2]
Amonafide + Dactinomycin DCKEFOR Dactinomycin Adenocarcinoma (Cell Line: HCT-15) [2]
Amonafide + Dactinomycin DC8MNX1 Dactinomycin Adenocarcinoma (Cell Line: HCC-2998) [2]
Amonafide + Dactinomycin DCRHZOL Dactinomycin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
Amonafide + Dactinomycin DC0S7HT Dactinomycin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Amonafide + Dactinomycin DCCIEMO Dactinomycin Anaplastic large cell lymphoma (Cell Line: SR) [2]
Amonafide + Dactinomycin DCP0NSO Dactinomycin Astrocytoma (Cell Line: U251) [2]
Amonafide + Dactinomycin DC6YICW Dactinomycin Astrocytoma (Cell Line: SNB-19) [2]
Amonafide + Dactinomycin DC7CL4K Dactinomycin Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [2]
Amonafide + Dactinomycin DC7IGM9 Dactinomycin Chronic myelogenous leukemia (Cell Line: K-562) [2]
Amonafide + Dactinomycin DC533MN Dactinomycin Clear cell renal cell carcinoma (Cell Line: A498) [2]
Amonafide + Dactinomycin DCFD5XW Dactinomycin Clear cell renal cell carcinoma (Cell Line: 786-0) [2]
Amonafide + Dactinomycin DC1I10R Dactinomycin Cutaneous melanoma (Cell Line: SK-MEL-28) [2]
Amonafide + Dactinomycin DCCDXZ0 Dactinomycin Glioma (Cell Line: SF-539) [2]
Amonafide + Dactinomycin DCZYN9A Dactinomycin Glioma (Cell Line: SF-268) [2]
Amonafide + Dactinomycin DCAJW0U Dactinomycin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [2]
Amonafide + Dactinomycin DCCB2Y2 Dactinomycin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [2]
Amonafide + Dactinomycin DCN2W4R Dactinomycin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [2]
Amonafide + Dactinomycin DCG7P9M Dactinomycin Large cell lung carcinoma (Cell Line: NCI-H460) [2]
Amonafide + Dactinomycin DCDA23N Dactinomycin Lung adenocarcinoma (Cell Line: EKVX) [2]
Amonafide + Dactinomycin DC64YD8 Dactinomycin Lung adenocarcinoma (Cell Line: HOP-62) [2]
Amonafide + Dactinomycin DCJ21AF Dactinomycin Lung adenocarcinoma (Cell Line: NCI-H522) [2]
Amonafide + Dactinomycin DCKJG6D Dactinomycin Malignant melanoma (Cell Line: LOX IMVI) [2]
Amonafide + Dactinomycin DCLY6Y6 Dactinomycin Melanoma (Cell Line: SK-MEL-2) [2]
Amonafide + Dactinomycin DCKQMWB Dactinomycin Melanoma (Cell Line: UACC-257) [2]
Amonafide + Dactinomycin DC8M1QG Dactinomycin Melanoma (Cell Line: MALME-3M) [2]
Amonafide + Dactinomycin DCSF4EZ Dactinomycin Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [2]
Amonafide + Dactinomycin DCAGQK2 Dactinomycin Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [2]
Amonafide + Dactinomycin DCQJCXY Dactinomycin Plasma cell myeloma (Cell Line: RPMI-8226) [2]
Amonafide + Dactinomycin DC0OJ3B Dactinomycin Renal cell carcinoma (Cell Line: SN12C) [2]
Amonafide + DFN-15 DCGRDY0 DFN-15 Adenocarcinoma (Cell Line: A549) [2]
Amonafide + DFN-15 DCY01FH DFN-15 Adenocarcinoma (Cell Line: HCT116) [2]
Amonafide + DFN-15 DCJ0YEY DFN-15 Chronic myelogenous leukemia (Cell Line: K-562) [2]
Amonafide + DFN-15 DC4UVDX DFN-15 Clear cell renal cell carcinoma (Cell Line: 786-0) [2]
Amonafide + DFN-15 DCDBEHC DFN-15 Lung adenocarcinoma (Cell Line: HOP-62) [2]
Amonafide + DFN-15 DCBQ1AC DFN-15 Renal cell carcinoma (Cell Line: SN12C) [2]
Amonafide + Lapatinib DCJHT1L Lapatinib Adenocarcinoma (Cell Line: DU-145) [2]
Amonafide + Lapatinib DCOU3Y5 Lapatinib Adenocarcinoma (Cell Line: A549) [2]
Amonafide + Lapatinib DCTYQ8W Lapatinib Adenocarcinoma (Cell Line: HCT-15) [2]
Amonafide + Lapatinib DCVU924 Lapatinib Adenocarcinoma (Cell Line: HCC-2998) [2]
Amonafide + Lapatinib DC5D830 Lapatinib Anaplastic large cell lymphoma (Cell Line: SR) [2]
Amonafide + Lapatinib DC1DJU9 Lapatinib Astrocytoma (Cell Line: SNB-19) [2]
Amonafide + Lapatinib DC6QN22 Lapatinib Clear cell renal cell carcinoma (Cell Line: A498) [2]
Amonafide + Lapatinib DCN5W34 Lapatinib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [2]
Amonafide + Lapatinib DCTAEH4 Lapatinib Lung adenocarcinoma (Cell Line: EKVX) [2]
Amonafide + Lapatinib DC9TBUN Lapatinib Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [2]
Amonafide + PMID28460551-Compound-2 DCRFEZ2 PMID28460551-Compound-2 Adenocarcinoma (Cell Line: DU-145) [2]
Amonafide + PMID28460551-Compound-2 DCSOMRN PMID28460551-Compound-2 Adenocarcinoma (Cell Line: A549) [2]
Amonafide + PMID28460551-Compound-2 DC7M7WY PMID28460551-Compound-2 Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Amonafide + PMID28460551-Compound-2 DC47UC4 PMID28460551-Compound-2 Anaplastic large cell lymphoma (Cell Line: SR) [2]
Amonafide + PMID28460551-Compound-2 DC9BEOH PMID28460551-Compound-2 Astrocytoma (Cell Line: U251) [2]
Amonafide + PMID28460551-Compound-2 DCPNUF8 PMID28460551-Compound-2 Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [2]
Amonafide + PMID28460551-Compound-2 DC7WTSX PMID28460551-Compound-2 Chronic myelogenous leukemia (Cell Line: K-562) [2]
Amonafide + PMID28460551-Compound-2 DCXWR0D PMID28460551-Compound-2 Large cell lung carcinoma (Cell Line: NCI-H460) [2]
Amonafide + PMID28460551-Compound-2 DC63AKQ PMID28460551-Compound-2 Lung adenocarcinoma (Cell Line: MDA-MB-231) [2]
Amonafide + PMID28460551-Compound-2 DCR1K8Q PMID28460551-Compound-2 Lung adenocarcinoma (Cell Line: EKVX) [2]
Amonafide + PMID28460551-Compound-2 DC7YWWR PMID28460551-Compound-2 Lung adenocarcinoma (Cell Line: HOP-62) [2]
Amonafide + PMID28460551-Compound-2 DCJRNSO PMID28460551-Compound-2 Plasma cell myeloma (Cell Line: RPMI-8226) [2]
Amonafide + PMID28460551-Compound-2 DCI1HPB PMID28460551-Compound-2 Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [2]
Amonafide + PMID28460551-Compound-2 DC5Z1LQ PMID28460551-Compound-2 Renal cell carcinoma (Cell Line: SN12C) [2]
Amonafide + Crizotinib DCERVDN Crizotinib Adenocarcinoma (Cell Line: DU-145) [2]
Amonafide + Crizotinib DCPQ80J Crizotinib Adenocarcinoma (Cell Line: HCT-15) [2]
Amonafide + Crizotinib DCOEKZ6 Crizotinib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Amonafide + Crizotinib DCSHO14 Crizotinib Glioma (Cell Line: SF-295) [2]
Amonafide + Crizotinib DCGHIC2 Crizotinib Malignant melanoma (Cell Line: LOX IMVI) [2]
Amonafide + Crizotinib DCUE8G0 Crizotinib Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [2]
Amonafide + LIAROZOLE DCWIA14 LIAROZOLE Adenocarcinoma (Cell Line: SW-620) [2]
Amonafide + LIAROZOLE DC1DSBV LIAROZOLE Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
Amonafide + LIAROZOLE DCM61TA LIAROZOLE Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Amonafide + LIAROZOLE DCSX2Q5 LIAROZOLE Glioma (Cell Line: SF-268) [2]
Amonafide + LIAROZOLE DCSSTEQ LIAROZOLE Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [2]
Amonafide + Panobinostat DCPHLTK Panobinostat Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [2]
Amonafide + Methotrexate DCVWUQP Methotrexate Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
Amonafide + Methotrexate DCIBR7Y Methotrexate Glioma (Cell Line: SF-539) [2]
Amonafide + Methotrexate DCBUSS4 Methotrexate Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [2]
Amonafide + Vemurafenib DCEFFUJ Vemurafenib Astrocytoma (Cell Line: U251) [2]
Amonafide + Plicamycin DCSX58R Plicamycin Adenocarcinoma (Cell Line: DU-145) [2]
Amonafide + Plicamycin DCQ96Q3 Plicamycin Adenocarcinoma (Cell Line: NCIH23) [2]
Amonafide + Plicamycin DCPSYXB Plicamycin Adenocarcinoma (Cell Line: HCT116) [2]
Amonafide + Plicamycin DCUZLKL Plicamycin Adenocarcinoma (Cell Line: HCC-2998) [2]
Amonafide + Plicamycin DCW570H Plicamycin Adenocarcinoma (Cell Line: HCT-15) [2]
Amonafide + Plicamycin DCIQJWI Plicamycin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Amonafide + Plicamycin DCGMJVI Plicamycin Astrocytoma (Cell Line: U251) [2]
Amonafide + Plicamycin DCE0OKI Plicamycin Chronic myelogenous leukemia (Cell Line: K-562) [2]
Amonafide + Plicamycin DC28KVR Plicamycin Clear cell renal cell carcinoma (Cell Line: 786-0) [2]
Amonafide + Plicamycin DCSOCE0 Plicamycin Cutaneous melanoma (Cell Line: SK-MEL-28) [2]
Amonafide + Plicamycin DCBL8S9 Plicamycin Glioma (Cell Line: SF-539) [2]
Amonafide + Plicamycin DC46TU2 Plicamycin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [2]
Amonafide + Plicamycin DC7OLNW Plicamycin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [2]
Amonafide + Plicamycin DCQUAIG Plicamycin Lung adenocarcinoma (Cell Line: HOP-62) [2]
Amonafide + Plicamycin DCP5JW3 Plicamycin Lung adenocarcinoma (Cell Line: NCI-H522) [2]
Amonafide + Plicamycin DCIYBII Plicamycin Melanoma (Cell Line: SK-MEL-2) [2]
Amonafide + Plicamycin DC8FUGO Plicamycin Melanoma (Cell Line: UACC-257) [2]
Amonafide + Plicamycin DCA17FS Plicamycin Melanoma (Cell Line: MALME-3M) [2]
Amonafide + Plicamycin DC1QCII Plicamycin Non-small cell lung carcinoma (Cell Line: HOP-92) [2]
Amonafide + Plicamycin DCENVZI Plicamycin Papillary renal cell carcinoma (Cell Line: ACHN) [2]
Amonafide + Plicamycin DCG1MZE Plicamycin Plasma cell myeloma (Cell Line: RPMI-8226) [2]
Amonafide + Plicamycin DCAXL1L Plicamycin Renal cell carcinoma (Cell Line: SN12C) [2]
Amonafide + Nilotinib DCXMU3U Nilotinib Adenocarcinoma (Cell Line: HCC-2998) [2]
Amonafide + Nilotinib DCMQBD1 Nilotinib Glioblastoma (Cell Line: SNB-75) [2]
Amonafide + Nilotinib DC1JQYC Nilotinib Lung adenocarcinoma (Cell Line: HOP-62) [2]
Amonafide + Thioguanine DCAL3GW Thioguanine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
Amonafide + Thioguanine DCF0SOI Thioguanine Anaplastic large cell lymphoma (Cell Line: SR) [2]
Amonafide + Thioguanine DCZNX1J Thioguanine Astrocytoma (Cell Line: SNB-19) [2]
Amonafide + Thioguanine DCCFB1M Thioguanine Clear cell renal cell carcinoma (Cell Line: 786-0) [2]
Amonafide + Thioguanine DC07G7Z Thioguanine Glioma (Cell Line: SF-268) [2]
Amonafide + Thioguanine DCQE1A8 Thioguanine Glioma (Cell Line: SF-539) [2]
Amonafide + Thioguanine DCXKLGV Thioguanine High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [2]
Amonafide + Thioguanine DCK63Z7 Thioguanine Lung adenocarcinoma (Cell Line: HOP-62) [2]
Amonafide + Thioguanine DCNPQW0 Thioguanine Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [2]
Amonafide + Thioguanine DCTNFE1 Thioguanine Papillary renal cell carcinoma (Cell Line: ACHN) [2]
Amonafide + Triapine DC11F50 Triapine Adenocarcinoma (Cell Line: NCIH23) [2]
Amonafide + Triapine DCYYEQR Triapine Adenocarcinoma (Cell Line: A549) [2]
Amonafide + Triapine DCWCNLL Triapine Adenocarcinoma (Cell Line: SW-620) [2]
Amonafide + Triapine DCDH70M Triapine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Amonafide + Triapine DCTJUF2 Triapine Anaplastic large cell lymphoma (Cell Line: SR) [2]
Amonafide + Triapine DCOHW11 Triapine Clear cell renal cell carcinoma (Cell Line: 786-0) [2]
Amonafide + Triapine DC73HSD Triapine Clear cell renal cell carcinoma (Cell Line: TK-10) [2]
Amonafide + Triapine DC3B45C Triapine Clear cell renal cell carcinoma (Cell Line: CAKI-1) [2]
Amonafide + Triapine DCPG3DT Triapine Glioma (Cell Line: SF-268) [2]
Amonafide + Triapine DCQOHC3 Triapine Glioma (Cell Line: SF-539) [2]
Amonafide + Triapine DCYW2H2 Triapine Large cell lung carcinoma (Cell Line: NCI-H460) [2]
Amonafide + Triapine DCYPUON Triapine Non-small cell lung carcinoma (Cell Line: HOP-92) [2]
Amonafide + 10-hydroxycamptothecin DC1BP5X 10-hydroxycamptothecin Adenocarcinoma (Cell Line: OVCAR3) [2]
Amonafide + 10-hydroxycamptothecin DCCUDXF 10-hydroxycamptothecin Adenocarcinoma (Cell Line: HT29) [2]
Amonafide + 10-hydroxycamptothecin DCJ4YOB 10-hydroxycamptothecin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
Amonafide + Topetecan DCPT0DJ Topetecan Adenocarcinoma (Cell Line: HT29) [2]
Amonafide + Topetecan DCNIF9N Topetecan Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
Amonafide + Topetecan DC1T41T Topetecan Anaplastic large cell lymphoma (Cell Line: SR) [2]
Amonafide + Topetecan DCWIIPI Topetecan Astrocytoma (Cell Line: U251) [2]
Amonafide + Topetecan DCKBJP1 Topetecan Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [2]
Amonafide + Topetecan DCSYJZA Topetecan Lung adenocarcinoma (Cell Line: EKVX) [2]
Amonafide + Pralatrexate DC6MHRH Pralatrexate Adenocarcinoma (Cell Line: NCIH23) [2]
Amonafide + Pralatrexate DCILAXN Pralatrexate Adenocarcinoma (Cell Line: A549) [2]
Amonafide + Pralatrexate DCQ09LU Pralatrexate Adenocarcinoma (Cell Line: HCT-15) [2]
Amonafide + Pralatrexate DCHHYSC Pralatrexate Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Amonafide + Pralatrexate DCRBCR9 Pralatrexate Astrocytoma (Cell Line: U251) [2]
Amonafide + Pralatrexate DCR4QEZ Pralatrexate Astrocytoma (Cell Line: SNB-19) [2]
Amonafide + Pralatrexate DCG9LXW Pralatrexate Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [2]
Amonafide + Pralatrexate DCZMKJY Pralatrexate Glioma (Cell Line: SF-295) [2]
Amonafide + Pralatrexate DC4GDJ3 Pralatrexate Plasma cell myeloma (Cell Line: RPMI-8226) [2]
Amonafide + Ifosfamide DCQXNK7 Ifosfamide Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Amonafide + Raloxifene DCGQMYF Raloxifene Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
Amonafide + Raloxifene DCLDF6Y Raloxifene Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Amonafide + Raloxifene DC8NB4H Raloxifene Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [2]
Amonafide + Raloxifene DCY6XOT Raloxifene Glioma (Cell Line: SF-539) [2]
Amonafide + Bendamustine hydrochloride DCCBITS Bendamustine hydrochloride Adenocarcinoma (Cell Line: A549) [2]
Amonafide + Bendamustine hydrochloride DCTMDM4 Bendamustine hydrochloride Adenocarcinoma (Cell Line: HCT116) [2]
Amonafide + Bendamustine hydrochloride DC57505 Bendamustine hydrochloride Adenocarcinoma (Cell Line: HCT-15) [2]
Amonafide + Bendamustine hydrochloride DCMSDM9 Bendamustine hydrochloride Adenocarcinoma (Cell Line: HT29) [2]
Amonafide + Bendamustine hydrochloride DCNM37B Bendamustine hydrochloride Adenocarcinoma (Cell Line: SW-620) [2]
Amonafide + Bendamustine hydrochloride DC87KOH Bendamustine hydrochloride Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Amonafide + Bendamustine hydrochloride DC3V0KS Bendamustine hydrochloride Anaplastic large cell lymphoma (Cell Line: SR) [2]
Amonafide + Bendamustine hydrochloride DCL08FE Bendamustine hydrochloride Astrocytoma (Cell Line: SNB-19) [2]
Amonafide + Bendamustine hydrochloride DCW4XC5 Bendamustine hydrochloride Chronic myelogenous leukemia (Cell Line: K-562) [2]
Amonafide + Bendamustine hydrochloride DCIZEEZ Bendamustine hydrochloride Cutaneous melanoma (Cell Line: SK-MEL-28) [2]
Amonafide + Bendamustine hydrochloride DCTNOYZ Bendamustine hydrochloride High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [2]
Amonafide + Bendamustine hydrochloride DC1GN3O Bendamustine hydrochloride Large cell lung carcinoma (Cell Line: NCI-H460) [2]
Amonafide + Bendamustine hydrochloride DC3KSIT Bendamustine hydrochloride Melanoma (Cell Line: MALME-3M) [2]
Amonafide + Bendamustine hydrochloride DCEBHRJ Bendamustine hydrochloride Plasma cell myeloma (Cell Line: RPMI-8226) [2]
Amonafide + Bendamustine hydrochloride DCU8B96 Bendamustine hydrochloride Prostate carcinoma (Cell Line: PC-3) [2]
Amonafide + Sirolimus DC0JHX0 Sirolimus Adenocarcinoma (Cell Line: NCIH23) [2]
Amonafide + Sirolimus DCYI2C6 Sirolimus Adenocarcinoma (Cell Line: SW-620) [2]
Amonafide + Sirolimus DC0G6US Sirolimus Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
Amonafide + Sirolimus DCK5Q3A Sirolimus Large cell lung carcinoma (Cell Line: NCI-H460) [2]
Amonafide + Mitomycin DCL29FR Mitomycin Adenocarcinoma (Cell Line: OVCAR3) [2]
Amonafide + Mitomycin DCRMTHT Mitomycin Adenocarcinoma (Cell Line: NCIH23) [2]
Amonafide + Mitomycin DCM7X2S Mitomycin Adenocarcinoma (Cell Line: HCT-15) [2]
Amonafide + Mitomycin DC2NR25 Mitomycin Adenocarcinoma (Cell Line: HCT116) [2]
Amonafide + Mitomycin DC3SET9 Mitomycin Adenocarcinoma (Cell Line: HT29) [2]
Amonafide + Mitomycin DCA0LIX Mitomycin Adenocarcinoma (Cell Line: SW-620) [2]
Amonafide + Mitomycin DCIG1NZ Mitomycin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
Amonafide + Mitomycin DCVZJF9 Mitomycin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Amonafide + Mitomycin DCSM3GE Mitomycin Anaplastic large cell lymphoma (Cell Line: SR) [2]
Amonafide + Mitomycin DCE71ML Mitomycin Astrocytoma (Cell Line: U251) [2]
Amonafide + Mitomycin DCFWKTU Mitomycin Astrocytoma (Cell Line: SNB-19) [2]
Amonafide + Mitomycin DC3C4QQ Mitomycin Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [2]
Amonafide + Mitomycin DCYTEHO Mitomycin Chronic myelogenous leukemia (Cell Line: K-562) [2]
Amonafide + Mitomycin DC519TC Mitomycin Clear cell renal cell carcinoma (Cell Line: 786-0) [2]
Amonafide + Mitomycin DC3I6CC Mitomycin Clear cell renal cell carcinoma (Cell Line: TK-10) [2]
Amonafide + Mitomycin DC524M3 Mitomycin Clear cell renal cell carcinoma (Cell Line: CAKI-1) [2]
Amonafide + Mitomycin DCDOOBH Mitomycin Glioblastoma (Cell Line: SNB-75) [2]
Amonafide + Mitomycin DCHCHYJ Mitomycin Glioma (Cell Line: SF-268) [2]
Amonafide + Mitomycin DCWIWGQ Mitomycin Lung adenocarcinoma (Cell Line: EKVX) [2]
Amonafide + Mitomycin DCSRGZM Mitomycin Lung adenocarcinoma (Cell Line: MDA-MB-231) [2]
Amonafide + Mitomycin DCV0F7I Mitomycin Melanoma (Cell Line: MALME-3M) [2]
Amonafide + Mitomycin DCCU0X9 Mitomycin Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [2]
Amonafide + Mitomycin DCA9O4T Mitomycin Non-small cell lung carcinoma (Cell Line: HOP-92) [2]
Amonafide + Mitomycin DC0NYOH Mitomycin Papillary renal cell carcinoma (Cell Line: ACHN) [2]
Amonafide + Mitomycin DC5NFX7 Mitomycin Plasma cell myeloma (Cell Line: RPMI-8226) [2]
Amonafide + Mitomycin DCGVBCW Mitomycin Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [2]
Amonafide + Mitomycin DCUTNSP Mitomycin Renal cell carcinoma (Cell Line: SN12C) [2]
Amonafide + SY-1425 DC9H3DO SY-1425 Glioma (Cell Line: SF-539) [2]
Amonafide + SY-1425 DC4ULPP SY-1425 Melanoma (Cell Line: MALME-3M) [2]
Amonafide + SY-1425 DC9IN3P SY-1425 Papillary renal cell carcinoma (Cell Line: ACHN) [2]
Amonafide + SY-1425 DCV7YQD SY-1425 Plasma cell myeloma (Cell Line: RPMI-8226) [2]
Amonafide + Uracil mustard DC6SA21 Uracil mustard Adenocarcinoma (Cell Line: OVCAR3) [2]
Amonafide + Uracil mustard DCUF41O Uracil mustard Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
Amonafide + Uracil mustard DC8LWD8 Uracil mustard Anaplastic large cell lymphoma (Cell Line: SR) [2]
Amonafide + Uracil mustard DCVUYYC Uracil mustard Astrocytoma (Cell Line: SNB-19) [2]
Amonafide + Uracil mustard DCMI4OD Uracil mustard Clear cell renal cell carcinoma (Cell Line: 786-0) [2]
Amonafide + Uracil mustard DCHB574 Uracil mustard Clear cell renal cell carcinoma (Cell Line: CAKI-1) [2]
Amonafide + Uracil mustard DCM681M Uracil mustard Glioblastoma (Cell Line: SNB-75) [2]
Amonafide + Uracil mustard DCDOFHS Uracil mustard Glioma (Cell Line: SF-268) [2]
Amonafide + Uracil mustard DCG8T8J Uracil mustard Glioma (Cell Line: SF-295) [2]
Amonafide + Uracil mustard DCHY6KH Uracil mustard High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [2]
Amonafide + Uracil mustard DCS32UT Uracil mustard High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [2]
Amonafide + Uracil mustard DCMEXZP Uracil mustard Large cell lung carcinoma (Cell Line: NCI-H460) [2]
Amonafide + Uracil mustard DC2YSTF Uracil mustard Lung adenocarcinoma (Cell Line: HOP-62) [2]
Amonafide + Uracil mustard DCXPP7O Uracil mustard Malignant melanoma (Cell Line: LOX IMVI) [2]
Amonafide + Uracil mustard DCS7NVV Uracil mustard Melanoma (Cell Line: SK-MEL-2) [2]
Amonafide + Uracil mustard DCQHAWJ Uracil mustard Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [2]
Amonafide + Uracil mustard DCZ3N1U Uracil mustard Non-small cell lung carcinoma (Cell Line: HOP-92) [2]
Amonafide + Uracil mustard DCDFJ89 Uracil mustard Papillary renal cell carcinoma (Cell Line: ACHN) [2]
Amonafide + Uracil mustard DCMX3US Uracil mustard Prostate carcinoma (Cell Line: PC-3) [2]
Amonafide + Vincristine DCOVWI2 Vincristine Adenocarcinoma (Cell Line: DU-145) [2]
Amonafide + Vincristine DCFMQZ0 Vincristine Adenocarcinoma (Cell Line: A549) [2]
Amonafide + Vincristine DCVFX46 Vincristine Adenocarcinoma (Cell Line: SW-620) [2]
Amonafide + Vincristine DCZ1STM Vincristine Adenocarcinoma (Cell Line: HCT116) [2]
Amonafide + Vincristine DCGARNE Vincristine Adenocarcinoma (Cell Line: HCT-15) [2]
Amonafide + Vincristine DCDPHB1 Vincristine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Amonafide + Vincristine DCK4QWA Vincristine Astrocytoma (Cell Line: U251) [2]
Amonafide + Vincristine DC2HR4A Vincristine Clear cell renal cell carcinoma (Cell Line: 786-0) [2]
Amonafide + Vincristine DCS8I24 Vincristine Clear cell renal cell carcinoma (Cell Line: A498) [2]
Amonafide + Vincristine DCHLWSL Vincristine Cutaneous melanoma (Cell Line: SK-MEL-5) [2]
Amonafide + Vincristine DC4K52B Vincristine Glioma (Cell Line: SF-268) [2]
Amonafide + Vincristine DCOE57D Vincristine Large cell lung carcinoma (Cell Line: NCI-H460) [2]
Amonafide + Vincristine DCC6WVF Vincristine Lung adenocarcinoma (Cell Line: HOP-62) [2]
Amonafide + Vincristine DCMBB49 Vincristine Non-small cell lung carcinoma (Cell Line: HOP-92) [2]
Amonafide + Vincristine DCY319L Vincristine Papillary renal cell carcinoma (Cell Line: ACHN) [2]
Amonafide + Arfolitixorin DC42ODQ Arfolitixorin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
Amonafide + Arfolitixorin DCW9VC2 Arfolitixorin Anaplastic large cell lymphoma (Cell Line: SR) [2]
Amonafide + Arfolitixorin DCBQIM9 Arfolitixorin Glioma (Cell Line: SF-268) [2]
Amonafide + Arfolitixorin DCH6E61 Arfolitixorin Large cell lung carcinoma (Cell Line: NCI-H460) [2]
Amonafide + Arfolitixorin DCE28IS Arfolitixorin Malignant melanoma (Cell Line: LOX IMVI) [2]
Amonafide + TEM DCV9D2B TEM Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [2]
Amonafide + JNK-IN-8 DCFIHSQ JNK-IN-8 Adenocarcinoma (Cell Line: HT29) [2]
Amonafide + Idarubicin DCG8CLU Idarubicin Anaplastic large cell lymphoma (Cell Line: SR) [2]
Amonafide + Idarubicin DCGCFR4 Idarubicin Glioblastoma? (Cell Line: T98G) [2]
Amonafide + Imatinib DCXL79S Imatinib Adenocarcinoma (Cell Line: HCT-15) [2]
Amonafide + Imatinib DCXDOOR Imatinib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Amonafide + Imatinib DCBWD1I Imatinib Chronic myelogenous leukemia (Cell Line: K-562) [2]
Amonafide + Imatinib DCTG33Q Imatinib Clear cell renal cell carcinoma (Cell Line: 786-0) [2]
Amonafide + Imatinib DCT95YY Imatinib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [2]
Amonafide + Bleomycin DCNIET4 Bleomycin Adenocarcinoma (Cell Line: DU-145) [2]
Amonafide + Bleomycin DCUHSSF Bleomycin Adenocarcinoma (Cell Line: A549) [2]
Amonafide + Bleomycin DCPJVG8 Bleomycin Adenocarcinoma (Cell Line: HT29) [2]
Amonafide + Bleomycin DCQVOPE Bleomycin Adenocarcinoma (Cell Line: HCT-15) [2]
Amonafide + Bleomycin DCPCDL1 Bleomycin Adenocarcinoma (Cell Line: SW-620) [2]
Amonafide + Bleomycin DC1BESM Bleomycin Adenocarcinoma (Cell Line: HCT116) [2]
Amonafide + Bleomycin DCG2878 Bleomycin Anaplastic large cell lymphoma (Cell Line: SR) [2]
Amonafide + Bleomycin DC43HFW Bleomycin Astrocytoma (Cell Line: U251) [2]
Amonafide + Bleomycin DCWGFT2 Bleomycin Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [2]
Amonafide + Bleomycin DCGLR48 Bleomycin Chronic myelogenous leukemia (Cell Line: K-562) [2]
Amonafide + Bleomycin DCHD8UH Bleomycin Clear cell renal cell carcinoma (Cell Line: TK-10) [2]
Amonafide + Bleomycin DCJ1UC5 Bleomycin Clear cell renal cell carcinoma (Cell Line: CAKI-1) [2]
Amonafide + Bleomycin DCDTXIP Bleomycin Glioma (Cell Line: SF-268) [2]
Amonafide + Bleomycin DCU0QZB Bleomycin Large cell lung carcinoma (Cell Line: NCI-H460) [2]
Amonafide + Bleomycin DC1N2TF Bleomycin Lung adenocarcinoma (Cell Line: HOP-62) [2]
Amonafide + Bleomycin DC1YJ0A Bleomycin Melanoma (Cell Line: SK-MEL-2) [2]
Amonafide + Bleomycin DCQR9XV Bleomycin Plasma cell myeloma (Cell Line: RPMI-8226) [2]
Amonafide + Bortezomib DCL05OX Bortezomib Adenocarcinoma (Cell Line: A549) [2]
Amonafide + Bortezomib DCV55EH Bortezomib Adenocarcinoma (Cell Line: HT29) [2]
Amonafide + Bortezomib DCR600T Bortezomib Adenocarcinoma (Cell Line: HCC-2998) [2]
Amonafide + Bortezomib DC0V3X9 Bortezomib Chronic myelogenous leukemia (Cell Line: K-562) [2]
Amonafide + Dacarbazine DC9FMER Dacarbazine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
Amonafide + Dacarbazine DCJQETA Dacarbazine Anaplastic large cell lymphoma (Cell Line: SR) [2]
Amonafide + Dacarbazine DCQLPXC Dacarbazine Glioma (Cell Line: SF-268) [2]
Amonafide + Dacarbazine DC0C4A2 Dacarbazine Malignant melanoma (Cell Line: LOX IMVI) [2]
Amonafide + Valrubicin DCA7UV3 Valrubicin Adenocarcinoma (Cell Line: NCIH23) [2]
Amonafide + Valrubicin DCPO364 Valrubicin Adenocarcinoma (Cell Line: HCT116) [2]
Amonafide + Valrubicin DCOF0C0 Valrubicin Adenocarcinoma (Cell Line: HCT-15) [2]
Amonafide + Valrubicin DC0ANMH Valrubicin Amelanotic melanoma (Cell Line: M14) [2]
Amonafide + Valrubicin DCM8V7Z Valrubicin Glioma (Cell Line: SF-268) [2]
Amonafide + Valrubicin DCP9CX2 Valrubicin Lung adenocarcinoma (Cell Line: HOP-62) [2]
Amonafide + Topotecan DCL4KW8 Topotecan Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
Amonafide + Topotecan DCUU39C Topotecan Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Amonafide + Topotecan DC2DYRD Topotecan Cutaneous melanoma (Cell Line: SK-MEL-28) [2]
Amonafide + Topotecan DC2ZY93 Topotecan Glioma (Cell Line: SF-268) [2]
Amonafide + Topotecan DCOTECA Topotecan High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [2]
Amonafide + Topotecan DCP6CH7 Topotecan High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [2]
Amonafide + Topotecan DCKV1G9 Topotecan Melanoma (Cell Line: MALME-3M) [2]
Amonafide + Topotecan DCMKMLZ Topotecan Melanoma (Cell Line: UACC-257) [2]
Amonafide + Topotecan DCOLL2U Topotecan Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [2]
Amonafide + Chlorambucil DCQPRFV Chlorambucil Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
Amonafide + Chlorambucil DCG08PA Chlorambucil Astrocytoma (Cell Line: U251) [2]
Amonafide + Chlorambucil DCZIQU8 Chlorambucil Melanoma (Cell Line: UACC-257) [2]
Amonafide + Sorafenib DCGOKVL Sorafenib Adenocarcinoma (Cell Line: DU-145) [2]
Amonafide + Sorafenib DC83V57 Sorafenib Adenocarcinoma (Cell Line: A549) [2]
Amonafide + Sorafenib DC0CSP6 Sorafenib Adenocarcinoma (Cell Line: HT29) [2]
Amonafide + Sorafenib DCH5MCG Sorafenib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Amonafide + Sorafenib DC5Z1SB Sorafenib Anaplastic large cell lymphoma (Cell Line: SR) [2]
Amonafide + Sorafenib DCMNXWZ Sorafenib Astrocytoma (Cell Line: U251) [2]
Amonafide + Sorafenib DCS0VY3 Sorafenib Astrocytoma (Cell Line: SNB-19) [2]
Amonafide + Sorafenib DCX83QN Sorafenib Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [2]
Amonafide + Sorafenib DCXM4SJ Sorafenib Large cell lung carcinoma (Cell Line: NCI-H460) [2]
Amonafide + Sorafenib DCS4I51 Sorafenib Malignant melanoma (Cell Line: UACC62) [2]
Amonafide + Sorafenib DCG1JI1 Sorafenib Malignant melanoma (Cell Line: LOX IMVI) [2]
Amonafide + Sorafenib DC7QCIU Sorafenib Plasma cell myeloma (Cell Line: RPMI-8226) [2]
Amonafide + Sorafenib DCABJLN Sorafenib Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [2]
Amonafide + ER819762 DCG1H8Y ER819762 Adenocarcinoma (Cell Line: OVCAR3) [2]
Amonafide + ER819762 DCJ3FHF ER819762 Adenocarcinoma (Cell Line: HCC-2998) [2]
Amonafide + Romidepsin DCTJB04 Romidepsin Adenocarcinoma (Cell Line: A549) [2]
Amonafide + Romidepsin DCCJ682 Romidepsin Adenocarcinoma (Cell Line: HT29) [2]
Amonafide + Romidepsin DCE3S4H Romidepsin Adenocarcinoma (Cell Line: HCT-15) [2]
Amonafide + Romidepsin DCZSAB5 Romidepsin Amelanotic melanoma (Cell Line: MDA-MB-435) [2]
Amonafide + Romidepsin DC76QKE Romidepsin Astrocytoma (Cell Line: U251) [2]
Amonafide + Romidepsin DCBEA7M Romidepsin Large cell lung carcinoma (Cell Line: NCI-H460) [2]
Amonafide + Romidepsin DCTE0YA Romidepsin Lung adenocarcinoma (Cell Line: EKVX) [2]
Amonafide + Romidepsin DC8RW78 Romidepsin Malignant melanoma (Cell Line: UACC62) [2]
Amonafide + Romidepsin DCSZNVQ Romidepsin Malignant melanoma (Cell Line: LOX IMVI) [2]
Amonafide + Romidepsin DCVLFRL Romidepsin Melanoma (Cell Line: MALME-3M) [2]
Amonafide + Romidepsin DCELCJ2 Romidepsin Plasma cell myeloma (Cell Line: RPMI-8226) [2]
Amonafide + Romidepsin DCFVNMP Romidepsin Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [2]
Amonafide + Azacitidine DCTUJF0 Azacitidine Adenocarcinoma (Cell Line: DU-145) [2]
Amonafide + Azacitidine DCPL0N2 Azacitidine Astrocytoma (Cell Line: SNB-19) [2]
Amonafide + Azacitidine DC8SPL8 Azacitidine Clear cell renal cell carcinoma (Cell Line: A498) [2]
Amonafide + Azacitidine DCRQNDO Azacitidine High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [2]
Amonafide + Azacitidine DCQ56KW Azacitidine Melanoma (Cell Line: SK-MEL-2) [2]
Amonafide + Azacitidine DCVK6SX Azacitidine Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [2]
Amonafide + Azacitidine DCFSKTZ Azacitidine Plasma cell myeloma (Cell Line: RPMI-8226) [2]
Amonafide + Vinflunine DC5U0PX Vinflunine Adenocarcinoma (Cell Line: HCT-15) [2]
Amonafide + Vinflunine DCNFACN Vinflunine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
Amonafide + Vinflunine DCVMZH2 Vinflunine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Amonafide + Vinflunine DC0YH00 Vinflunine Anaplastic large cell lymphoma (Cell Line: SR) [2]
Amonafide + Vinflunine DC22S8F Vinflunine Astrocytoma (Cell Line: U251) [2]
Amonafide + Vinflunine DCB9O8K Vinflunine Large cell lung carcinoma (Cell Line: NCI-H460) [2]
Amonafide + Vinflunine DCSPR9B Vinflunine Non-small cell lung carcinoma (Cell Line: HOP-92) [2]
Amonafide + Mercaptopurine DC9UGZ1 Mercaptopurine Adenocarcinoma (Cell Line: NCIH23) [2]
Amonafide + Mercaptopurine DCYHYUS Mercaptopurine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
Amonafide + Mercaptopurine DCXZTCV Mercaptopurine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Amonafide + Mercaptopurine DCVUMK2 Mercaptopurine Anaplastic large cell lymphoma (Cell Line: SR) [2]
Amonafide + Mercaptopurine DCLO539 Mercaptopurine Astrocytoma (Cell Line: SNB-19) [2]
Amonafide + Mercaptopurine DCC3PHH Mercaptopurine Large cell lung carcinoma (Cell Line: NCI-H460) [2]
Amonafide + Mercaptopurine DCMUWBC Mercaptopurine Plasma cell myeloma (Cell Line: RPMI-8226) [2]
Amonafide + Mepacrine DCEXWGY Mepacrine Clear cell renal cell carcinoma (Cell Line: A498) [2]
Amonafide + Mepacrine DCFVE67 Mepacrine Renal cell carcinoma (Cell Line: UO-31) [2]
Amonafide + Taxol DC05JUS Taxol Adenocarcinoma (Cell Line: NCIH23) [2]
Amonafide + Taxol DCXI4FL Taxol Adenocarcinoma (Cell Line: HCT-15) [2]
Amonafide + Taxol DCQPDNN Taxol Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Amonafide + Taxol DCJ4EQ2 Taxol Astrocytoma (Cell Line: U251) [2]
Amonafide + Taxol DCRYZ9N Taxol Chronic myelogenous leukemia (Cell Line: K-562) [2]
Amonafide + Taxol DCA10N3 Taxol Lung adenocarcinoma (Cell Line: HOP-62) [2]
Amonafide + Fludarabine DC2B5S0 Fludarabine Adenocarcinoma (Cell Line: DU-145) [2]
Amonafide + Fludarabine DCJ6I7B Fludarabine Adenocarcinoma (Cell Line: NCIH23) [2]
Amonafide + Fludarabine DCICTR4 Fludarabine Adenocarcinoma (Cell Line: HCT-15) [2]
Amonafide + Fludarabine DC67NDI Fludarabine Adenocarcinoma (Cell Line: HCT116) [2]
Amonafide + Fludarabine DCQB2DD Fludarabine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
Amonafide + Fludarabine DCBW7AC Fludarabine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Amonafide + Fludarabine DCXX0UV Fludarabine Astrocytoma (Cell Line: U251) [2]
Amonafide + Fludarabine DCZQQQM Fludarabine Clear cell renal cell carcinoma (Cell Line: CAKI-1) [2]
Amonafide + Fludarabine DCTDNJI Fludarabine Glioma (Cell Line: SF-268) [2]
Amonafide + Fludarabine DCOS106 Fludarabine Large cell lung carcinoma (Cell Line: NCI-H460) [2]
Amonafide + Fludarabine DC08O4Q Fludarabine Lung adenocarcinoma (Cell Line: HOP-62) [2]
Amonafide + Fludarabine DCX2852 Fludarabine Malignant melanoma (Cell Line: LOX IMVI) [2]
Amonafide + Fludarabine DCHEUC3 Fludarabine Papillary renal cell carcinoma (Cell Line: ACHN) [2]
Amonafide + PMID28870136-Compound-43 DCX2CJQ PMID28870136-Compound-43 Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Amonafide + FORMESTANE DC7QQQ8 FORMESTANE Adenocarcinoma (Cell Line: DU-145) [2]
Amonafide + FORMESTANE DC54JII FORMESTANE Lung adenocarcinoma (Cell Line: EKVX) [2]
Amonafide + Aminolevulinic Acid Hydrochloride DCY4Q3B Aminolevulinic Acid Hydrochloride Adenocarcinoma (Cell Line: HCT116) [2]
Amonafide + Aminolevulinic Acid Hydrochloride DCT354A Aminolevulinic Acid Hydrochloride Adenocarcinoma (Cell Line: HT29) [2]
Amonafide + Aminolevulinic Acid Hydrochloride DCUW1HF Aminolevulinic Acid Hydrochloride Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
Amonafide + Aminolevulinic Acid Hydrochloride DCOXEXE Aminolevulinic Acid Hydrochloride Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Amonafide + Aminolevulinic Acid Hydrochloride DCWNOS3 Aminolevulinic Acid Hydrochloride Anaplastic large cell lymphoma (Cell Line: SR) [2]
Amonafide + Aminolevulinic Acid Hydrochloride DCI9PV3 Aminolevulinic Acid Hydrochloride Clear cell renal cell carcinoma (Cell Line: A498) [2]
Amonafide + Aminolevulinic Acid Hydrochloride DC1G1MF Aminolevulinic Acid Hydrochloride Large cell lung carcinoma (Cell Line: NCI-H460) [2]
Amonafide + Aminolevulinic Acid Hydrochloride DCN50QR Aminolevulinic Acid Hydrochloride Renal cell carcinoma (Cell Line: SN12C) [2]
Amonafide + Estramustine DC3WADT Estramustine Adenocarcinoma (Cell Line: NCIH23) [2]
Amonafide + Estramustine DCTNH1N Estramustine Adenocarcinoma (Cell Line: HCT-15) [2]
Amonafide + Estramustine DC8XHPU Estramustine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Amonafide + Estramustine DCP4Z6G Estramustine Astrocytoma (Cell Line: U251) [2]
Amonafide + Estramustine DCEWGCP Estramustine Clear cell renal cell carcinoma (Cell Line: 786-0) [2]
Amonafide + Estramustine DC0WFRX Estramustine Glioma (Cell Line: SF-268) [2]
Amonafide + Estramustine DCR2VU7 Estramustine Non-small cell lung carcinoma (Cell Line: HOP-92) [2]
Amonafide + Digitoxin DCZC6HY Digitoxin Adenocarcinoma (Cell Line: DU-145) [2]
Amonafide + Digitoxin DC84S2B Digitoxin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
Amonafide + Digitoxin DC4QVPI Digitoxin Anaplastic large cell lymphoma (Cell Line: SR) [2]
Amonafide + Digitoxin DCKB09K Digitoxin Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [2]
Amonafide + Digitoxin DC2BSCR Digitoxin Chronic myelogenous leukemia (Cell Line: K-562) [2]
Amonafide + Digitoxin DCBCDZZ Digitoxin Clear cell renal cell carcinoma (Cell Line: A498) [2]
Amonafide + Digitoxin DCZJNIA Digitoxin Glioma (Cell Line: SF-539) [2]
Amonafide + Digitoxin DCTD209 Digitoxin Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [2]
Amonafide + Busulfan DCM75HL Busulfan Adenocarcinoma (Cell Line: NCIH23) [2]
Amonafide + Busulfan DCI3K9B Busulfan Adenocarcinoma (Cell Line: SW-620) [2]
Amonafide + Busulfan DCAJTA9 Busulfan Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
Amonafide + Busulfan DCEBNQD Busulfan Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Amonafide + Busulfan DC53V0C Busulfan Anaplastic large cell lymphoma (Cell Line: SR) [2]
Amonafide + Busulfan DCVCL3V Busulfan Astrocytoma (Cell Line: U251) [2]
Amonafide + Busulfan DCQ5NWB Busulfan Chronic myelogenous leukemia (Cell Line: K-562) [2]
Amonafide + Busulfan DCZT9S8 Busulfan Glioma (Cell Line: SF-268) [2]
Amonafide + Busulfan DCNQ0L0 Busulfan Glioma (Cell Line: SF-539) [2]
Amonafide + Busulfan DCJAVRL Busulfan Plasma cell myeloma (Cell Line: RPMI-8226) [2]
Amonafide + Dasatinib DC9TZF1 Dasatinib Adenocarcinoma (Cell Line: A549) [2]
Amonafide + Dasatinib DC2G669 Dasatinib Adenocarcinoma (Cell Line: NCIH23) [2]
Amonafide + Dasatinib DC6HI2H Dasatinib Adenocarcinoma (Cell Line: HCT116) [2]
Amonafide + Dasatinib DCMFT99 Dasatinib Adenocarcinoma (Cell Line: HCC-2998) [2]
Amonafide + Dasatinib DC7CD0V Dasatinib Astrocytoma (Cell Line: U251) [2]
Amonafide + Dasatinib DC3X26U Dasatinib Astrocytoma (Cell Line: SNB-19) [2]
Amonafide + Dasatinib DCNB84Z Dasatinib Chronic myelogenous leukemia (Cell Line: K-562) [2]
Amonafide + Dasatinib DCB4WQP Dasatinib Clear cell renal cell carcinoma (Cell Line: TK-10) [2]
Amonafide + Dasatinib DCM1JVF Dasatinib Clear cell renal cell carcinoma (Cell Line: 786-0) [2]
Amonafide + Dasatinib DCZN612 Dasatinib Clear cell renal cell carcinoma (Cell Line: CAKI-1) [2]
Amonafide + Dasatinib DCA5WAJ Dasatinib Glioblastoma (Cell Line: SNB-75) [2]
Amonafide + Dasatinib DCKX3A1 Dasatinib Glioma (Cell Line: SF-295) [2]
Amonafide + Dasatinib DCOFN3Y Dasatinib Large cell lung carcinoma (Cell Line: NCI-H460) [2]
Amonafide + Dasatinib DCE6YPE Dasatinib Lung adenocarcinoma (Cell Line: EKVX) [2]
Amonafide + Dasatinib DCHFVN5 Dasatinib Lung adenocarcinoma (Cell Line: MDA-MB-231) [2]
Amonafide + Dasatinib DC1KS8Y Dasatinib Lung adenocarcinoma (Cell Line: NCI-H522) [2]
Amonafide + Dasatinib DCQO2AW Dasatinib Non-small cell lung carcinoma (Cell Line: HOP-92) [2]
Amonafide + Dasatinib DC2XHX7 Dasatinib Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [2]
Amonafide + Dasatinib DC7QLPE Dasatinib Papillary renal cell carcinoma (Cell Line: ACHN) [2]
Amonafide + Dasatinib DCMY4QQ Dasatinib Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [2]
Amonafide + Dasatinib DC9BCH2 Dasatinib Renal cell carcinoma (Cell Line: SN12C) [2]
Amonafide + Mechlorethamine DCEQGUW Mechlorethamine Colon adenocarcinoma (Cell Line: COLO 205) [3]
Amonafide + Hepzato DCFACQZ Hepzato Carcinoma (Cell Line: MCF7) [3]
Amonafide + Hepzato DCTTL43 Hepzato Invasive ductal carcinoma (Cell Line: HS 578T) [3]
Amonafide + Dactinomycin DCFVXN1 Dactinomycin Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
Amonafide + Dactinomycin DCR86KW Dactinomycin Carcinoma (Cell Line: RXF 393) [3]
Amonafide + Dactinomycin DCUVA0P Dactinomycin Colon adenocarcinoma (Cell Line: COLO 205) [3]
Amonafide + PMID28460551-Compound-2 DCHU064 PMID28460551-Compound-2 Carcinoma (Cell Line: RXF 393) [3]
Amonafide + PMID28460551-Compound-2 DC3ATEG PMID28460551-Compound-2 Carcinoma (Cell Line: MCF7) [3]
Amonafide + PMID28460551-Compound-2 DC37UGO PMID28460551-Compound-2 Colon adenocarcinoma (Cell Line: COLO 205) [3]
Amonafide + PMID28460551-Compound-2 DCFLRLM PMID28460551-Compound-2 Colon carcinoma (Cell Line: KM12) [3]
Amonafide + PMID28460551-Compound-2 DCO4R24 PMID28460551-Compound-2 Invasive ductal carcinoma (Cell Line: HS 578T) [3]
Amonafide + PMID28460551-Compound-2 DCG7HYI PMID28460551-Compound-2 Invasive ductal carcinoma (Cell Line: BT-549) [3]
Amonafide + LIAROZOLE DCDKV2X LIAROZOLE Colon adenocarcinoma (Cell Line: COLO 205) [3]
Amonafide + Methotrexate DCWFD2X Methotrexate Colon adenocarcinoma (Cell Line: COLO 205) [3]
Amonafide + Plicamycin DCM04C8 Plicamycin Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
Amonafide + Plicamycin DCHU68A Plicamycin Carcinoma (Cell Line: RXF 393) [3]
Amonafide + Plicamycin DCYNTZ4 Plicamycin Invasive ductal carcinoma (Cell Line: HS 578T) [3]
Amonafide + Plicamycin DCMONJU Plicamycin Invasive ductal carcinoma (Cell Line: BT-549) [3]
Amonafide + Thioguanine DCY7DHJ Thioguanine Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
Amonafide + Thioguanine DC9HLSK Thioguanine Carcinoma (Cell Line: RXF 393) [3]
Amonafide + Thioguanine DCBPC48 Thioguanine Colon adenocarcinoma (Cell Line: COLO 205) [3]
Amonafide + Triapine DCMRT5G Triapine Carcinoma (Cell Line: MCF7) [3]
Amonafide + Triapine DCFV8VG Triapine Invasive ductal carcinoma (Cell Line: BT-549) [3]
Amonafide + Terameprocol DCFVBUO Terameprocol Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
Amonafide + Ifosfamide DCIXB1S Ifosfamide Invasive ductal carcinoma (Cell Line: BT-549) [3]
Amonafide + Bendamustine hydrochloride DC5J4FQ Bendamustine hydrochloride Colon adenocarcinoma (Cell Line: COLO 205) [3]
Amonafide + Mitomycin DCXIB87 Mitomycin Carcinoma (Cell Line: RXF 393) [3]
Amonafide + Mitomycin DCCMOW0 Mitomycin Carcinoma (Cell Line: MCF7) [3]
Amonafide + Mitomycin DCIOYZD Mitomycin Colon adenocarcinoma (Cell Line: COLO 205) [3]
Amonafide + Mitomycin DCO3TZV Mitomycin Invasive ductal carcinoma (Cell Line: BT-549) [3]
Amonafide + Mitomycin DCG34F7 Mitomycin Invasive ductal carcinoma (Cell Line: HS 578T) [3]
Amonafide + SY-1425 DCXL28C SY-1425 Carcinoma (Cell Line: MCF7) [3]
Amonafide + SY-1425 DCD01T0 SY-1425 Colon carcinoma (Cell Line: KM12) [3]
Amonafide + SY-1425 DCNRE8R SY-1425 Invasive ductal carcinoma (Cell Line: HS 578T) [3]
Amonafide + Uracil mustard DC2OJOQ Uracil mustard Colon adenocarcinoma (Cell Line: COLO 205) [3]
Amonafide + Uracil mustard DCYEYNI Uracil mustard Colon carcinoma (Cell Line: KM12) [3]
Amonafide + Uracil mustard DC4QF8Q Uracil mustard Invasive ductal carcinoma (Cell Line: HS 578T) [3]
Amonafide + Vincristine DC7EHVI Vincristine Invasive ductal carcinoma (Cell Line: BT-549) [3]
Amonafide + Arfolitixorin DCGUCD8 Arfolitixorin Carcinoma (Cell Line: RXF 393) [3]
Amonafide + Arfolitixorin DC6KQ78 Arfolitixorin Colon adenocarcinoma (Cell Line: COLO 205) [3]
Amonafide + Arfolitixorin DCZLLFO Arfolitixorin Colon carcinoma (Cell Line: KM12) [3]
Amonafide + Altretamine DC2ZDFT Altretamine Invasive ductal carcinoma (Cell Line: BT-549) [3]
Amonafide + Bleomycin DCRZUA9 Bleomycin Carcinoma (Cell Line: MCF7) [3]
Amonafide + Bleomycin DCSXEP4 Bleomycin Colon adenocarcinoma (Cell Line: COLO 205) [3]
Amonafide + Bleomycin DCJ6STI Bleomycin Invasive ductal carcinoma (Cell Line: HS 578T) [3]
Amonafide + Bleomycin DCLJWK3 Bleomycin Invasive ductal carcinoma (Cell Line: BT-549) [3]
Amonafide + Bortezomib DCVAIZ1 Bortezomib Colon adenocarcinoma (Cell Line: COLO 205) [3]
Amonafide + Topotecan DCXY910 Topotecan Invasive ductal carcinoma (Cell Line: HS 578T) [3]
Amonafide + Chlorambucil DCDKKN3 Chlorambucil Invasive ductal carcinoma (Cell Line: BT-549) [3]
Amonafide + Sorafenib DC98MUW Sorafenib Colon adenocarcinoma (Cell Line: COLO 205) [3]
Amonafide + Romidepsin DCMY1LU Romidepsin Invasive ductal carcinoma (Cell Line: HS 578T) [3]
Amonafide + Romidepsin DCHUBHY Romidepsin Invasive ductal carcinoma (Cell Line: T-47D) [3]
Amonafide + Romidepsin DC9S0JK Romidepsin Invasive ductal carcinoma (Cell Line: BT-549) [3]
Amonafide + Vinflunine DCRE1YA Vinflunine Carcinoma (Cell Line: MCF7) [3]
Amonafide + Vinflunine DCIG1BM Vinflunine Invasive ductal carcinoma (Cell Line: HS 578T) [3]
Amonafide + Mercaptopurine DCW3RNH Mercaptopurine Colon adenocarcinoma (Cell Line: COLO 205) [3]
Amonafide + Taxol DC59TQ3 Taxol Colon adenocarcinoma (Cell Line: COLO 205) [3]
Amonafide + Fludarabine DCXOK66 Fludarabine Carcinoma (Cell Line: MCF7) [3]
Amonafide + Fludarabine DCAX3HC Fludarabine Invasive ductal carcinoma (Cell Line: HS 578T) [3]
Amonafide + Fludarabine DCTVVZJ Fludarabine Invasive ductal carcinoma (Cell Line: T-47D) [3]
Amonafide + Aminolevulinic Acid Hydrochloride DC3MMRI Aminolevulinic Acid Hydrochloride Colon adenocarcinoma (Cell Line: COLO 205) [3]
Amonafide + Aminolevulinic Acid Hydrochloride DCKTNFA Aminolevulinic Acid Hydrochloride Invasive ductal carcinoma (Cell Line: HS 578T) [3]
Amonafide + Aminolevulinic Acid Hydrochloride DC9QZGS Aminolevulinic Acid Hydrochloride Invasive ductal carcinoma (Cell Line: T-47D) [3]
Amonafide + Busulfan DCH4LXP Busulfan Colon adenocarcinoma (Cell Line: COLO 205) [3]
Amonafide + Dasatinib DCIKQMJ Dasatinib Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
Anastrozole + Amonafide DC4OJYY Anastrozole Adenocarcinoma (Cell Line: HCT116) [2]
Anastrozole + Amonafide DCG9A5Z Anastrozole Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
Anastrozole + Amonafide DCTLVEO Anastrozole Anaplastic large cell lymphoma (Cell Line: SR) [2]
Anastrozole + Amonafide DCK4LYX Anastrozole Glioma (Cell Line: SF-268) [2]
Anastrozole + Amonafide DC49VKO Anastrozole High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [2]
Anastrozole + Amonafide DC2JGFN Anastrozole High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [2]
Anastrozole + Amonafide DCIIUP3 Anastrozole High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [2]
Anastrozole + Amonafide DC72IMQ Anastrozole Large cell lung carcinoma (Cell Line: NCI-H460) [2]
Anastrozole + Amonafide DCH8FK5 Anastrozole Malignant melanoma (Cell Line: LOX IMVI) [2]
Anastrozole + Amonafide DC0KYU7 Anastrozole Melanoma (Cell Line: UACC-257) [2]
Anastrozole + Amonafide DC5SOBK Anastrozole Non-small cell lung carcinoma (Cell Line: HOP-92) [2]
Anastrozole + Amonafide DCZE5IG Anastrozole Prostate carcinoma (Cell Line: PC-3) [2]
Anastrozole + Amonafide DCNAKNX Anastrozole Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
Anastrozole + Amonafide DC1ECGU Anastrozole Colon carcinoma (Cell Line: KM12) [3]
Anastrozole + Amonafide DC8NUM7 Anastrozole Invasive ductal carcinoma (Cell Line: HS 578T) [3]
BIO-300 + Amonafide DC2XRPS BIO-300 Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
BIO-300 + Amonafide DCFWU2Y BIO-300 Anaplastic large cell lymphoma (Cell Line: SR) [2]
BIO-300 + Amonafide DCL4WO5 BIO-300 Astrocytoma (Cell Line: SNB-19) [2]
BIO-300 + Amonafide DC36X6W BIO-300 Chronic myelogenous leukemia (Cell Line: K-562) [2]
BIO-300 + Amonafide DC1G5G5 BIO-300 Clear cell renal cell carcinoma (Cell Line: 786-0) [2]
BIO-300 + Amonafide DCU4X53 BIO-300 Clear cell renal cell carcinoma (Cell Line: TK-10) [2]
BIO-300 + Amonafide DCHAS80 BIO-300 Glioblastoma (Cell Line: SNB-75) [2]
BIO-300 + Amonafide DCQTJUY BIO-300 Papillary renal cell carcinoma (Cell Line: ACHN) [2]
BIO-300 + Amonafide DCQS7U0 BIO-300 Colon adenocarcinoma (Cell Line: COLO 205) [3]
BIO-300 + Amonafide DC9MV0H BIO-300 Invasive ductal carcinoma (Cell Line: HS 578T) [3]
BIO-300 + Amonafide DCKVELM BIO-300 Lung adenocarcinoma (Cell Line: EKVX) [4]
BIO-300 + Amonafide DC8HW9K BIO-300 Malignant melanoma (Cell Line: LOX IMVI) [4]
BIO-300 + Amonafide DCQ9NIE BIO-300 Malignant melanoma (Cell Line: UACC62) [4]
Bleomycin + Amonafide DCMTHP6 Bleomycin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
Bleomycin + Amonafide DCRJQHM Bleomycin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Bleomycin + Amonafide DC3JTP7 Bleomycin Anaplastic large cell lymphoma (Cell Line: SR) [2]
Bleomycin + Amonafide DCPQ3EJ Bleomycin Astrocytoma (Cell Line: U251) [2]
Bleomycin + Amonafide DCV6R2H Bleomycin Chronic myelogenous leukemia (Cell Line: K-562) [2]
Bleomycin + Amonafide DCJ6K17 Bleomycin Glioma (Cell Line: SF-539) [2]
Bleomycin + Amonafide DCN1HIX Bleomycin Glioma (Cell Line: SF-268) [2]
Bleomycin + Amonafide DC1OR1P Bleomycin Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
Bleomycin + Amonafide DCW85OZ Bleomycin Colon adenocarcinoma (Cell Line: COLO 205) [3]
Bleomycin + Amonafide DC4PW42 Bleomycin Colon carcinoma (Cell Line: KM12) [3]
Bleomycin + Amonafide DCGJKZD Bleomycin Invasive ductal carcinoma (Cell Line: HS 578T) [3]
Bleomycin + Amonafide DCGQ9G7 Bleomycin Adenocarcinoma (Cell Line: OVCAR3) [4]
Bleomycin + Amonafide DC5TW0M Bleomycin Adenocarcinoma (Cell Line: NCIH23) [4]
Bleomycin + Amonafide DCQK5U4 Bleomycin Cutaneous melanoma (Cell Line: SK-MEL-5) [4]
Bleomycin + Amonafide DCA9RRR Bleomycin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [4]
Bleomycin + Amonafide DC5RG33 Bleomycin Large cell lung carcinoma (Cell Line: NCI-H460) [4]
Bleomycin + Amonafide DCE4RS1 Bleomycin Lung adenocarcinoma (Cell Line: EKVX) [4]
Bleomycin + Amonafide DC6MSQ0 Bleomycin Lung adenocarcinoma (Cell Line: HOP-62) [4]
Bleomycin + Amonafide DCXNKY5 Bleomycin Malignant melanoma (Cell Line: LOX IMVI) [4]
Cabazitaxel + Amonafide DCUMU0C Cabazitaxel Adenocarcinoma (Cell Line: HCT-15) [2]
Cabazitaxel + Amonafide DC31FLC Cabazitaxel Adenocarcinoma (Cell Line: HT29) [2]
Cabazitaxel + Amonafide DCKR0NL Cabazitaxel Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
Cabazitaxel + Amonafide DCCC10S Cabazitaxel Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Cabazitaxel + Amonafide DC3M20K Cabazitaxel Astrocytoma (Cell Line: SNB-19) [2]
Cabazitaxel + Amonafide DCVS3YN Cabazitaxel Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [2]
Cabazitaxel + Amonafide DCSKOG9 Cabazitaxel Clear cell renal cell carcinoma (Cell Line: 786-0) [2]
Cabazitaxel + Amonafide DC3OAP6 Cabazitaxel Large cell lung carcinoma (Cell Line: NCI-H460) [2]
Cabazitaxel + Amonafide DCRV97B Cabazitaxel Prostate carcinoma (Cell Line: PC-3) [2]
Cabazitaxel + Amonafide DCANWID Cabazitaxel Renal cell carcinoma (Cell Line: SN12C) [2]
Crizotinib + Amonafide DC79UG9 Crizotinib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Crizotinib + Amonafide DCYLJ8E Crizotinib Astrocytoma (Cell Line: SNB-19) [2]
Crizotinib + Amonafide DCV43L8 Crizotinib Clear cell renal cell carcinoma (Cell Line: 786-0) [2]
Crizotinib + Amonafide DCVM6AV Crizotinib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [2]
Crizotinib + Amonafide DCMKZWP Crizotinib Large cell lung carcinoma (Cell Line: NCI-H460) [2]
Crizotinib + Amonafide DC7WJ1M Crizotinib Renal cell carcinoma (Cell Line: SN12C) [2]
Crizotinib + Amonafide DCTOCWO Crizotinib Colon carcinoma (Cell Line: KM12) [3]
Dexrazoxane + Amonafide DCXWYM2 Dexrazoxane Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
Dexrazoxane + Amonafide DCLU4RL Dexrazoxane Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Dexrazoxane + Amonafide DC5WJ3G Dexrazoxane Anaplastic large cell lymphoma (Cell Line: SR) [2]
Dexrazoxane + Amonafide DCSOJ0S Dexrazoxane Astrocytoma (Cell Line: U251) [2]
Dexrazoxane + Amonafide DCEIHBB Dexrazoxane Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [2]
Dexrazoxane + Amonafide DCGOH7K Dexrazoxane Chronic myelogenous leukemia (Cell Line: K-562) [2]
Dexrazoxane + Amonafide DCCYSX6 Dexrazoxane Clear cell renal cell carcinoma (Cell Line: TK-10) [2]
Dexrazoxane + Amonafide DC20PZG Dexrazoxane Glioma (Cell Line: SF-539) [2]
Dexrazoxane + Amonafide DCWBM6B Dexrazoxane Glioma (Cell Line: SF-268) [2]
Dexrazoxane + Amonafide DCLU9JC Dexrazoxane Renal cell carcinoma (Cell Line: SN12C) [2]
Dexrazoxane + Amonafide DCST2BW Dexrazoxane Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
Dexrazoxane + Amonafide DCF2O13 Dexrazoxane Colon adenocarcinoma (Cell Line: COLO 205) [3]
Dexrazoxane + Amonafide DCH8JHY Dexrazoxane Invasive ductal carcinoma (Cell Line: HS 578T) [3]
Dexrazoxane + Amonafide DCWQCOT Dexrazoxane Cutaneous melanoma (Cell Line: SK-MEL-5) [4]
Dexrazoxane + Amonafide DC8GXLC Dexrazoxane High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [4]
Dexrazoxane + Amonafide DC0ZC1P Dexrazoxane High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [4]
Dexrazoxane + Amonafide DCG92IZ Dexrazoxane High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [4]
Dexrazoxane + Amonafide DC7N1ZO Dexrazoxane Large cell lung carcinoma (Cell Line: NCI-H460) [4]
Dexrazoxane + Amonafide DCS11A4 Dexrazoxane Malignant melanoma (Cell Line: LOX IMVI) [4]
Dexrazoxane + Amonafide DCW3T3D Dexrazoxane Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [4]
Dexrazoxane + Amonafide DCSEE3U Dexrazoxane Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [4]
Epirubicin + Amonafide DC5OBCV Epirubicin Clear cell renal cell carcinoma (Cell Line: CAKI-1) [2]
Gefitinib + Amonafide DC47UBC Gefitinib Adenocarcinoma (Cell Line: NCIH23) [2]
Gefitinib + Amonafide DCPHWC7 Gefitinib Anaplastic large cell lymphoma (Cell Line: SR) [2]
Gefitinib + Amonafide DCPYZCK Gefitinib Astrocytoma (Cell Line: U251) [2]
Gefitinib + Amonafide DCR47PP Gefitinib Glioma (Cell Line: SF-268) [2]
Gefitinib + Amonafide DCJY49S Gefitinib Glioma (Cell Line: SF-539) [2]
Gefitinib + Amonafide DCPY6AH Gefitinib Large cell lung carcinoma (Cell Line: NCI-H460) [2]
Gefitinib + Amonafide DCMB8GA Gefitinib Lung adenocarcinoma (Cell Line: HOP-62) [2]
Gefitinib + Amonafide DC5GMYZ Gefitinib Lung adenocarcinoma (Cell Line: EKVX) [2]
Gefitinib + Amonafide DC8QMPE Gefitinib Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [2]
Gefitinib + Amonafide DC3H1XH Gefitinib Papillary renal cell carcinoma (Cell Line: ACHN) [2]
Gefitinib + Amonafide DCB9USH Gefitinib Prostate carcinoma (Cell Line: PC-3) [2]
Gefitinib + Amonafide DC85FF2 Gefitinib Renal cell carcinoma (Cell Line: UO-31) [2]
Gefitinib + Amonafide DCWA5N2 Gefitinib Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
Gefitinib + Amonafide DCAG87I Gefitinib Colon carcinoma (Cell Line: KM12) [3]
Gefitinib + Amonafide DC0RAGL Gefitinib Invasive ductal carcinoma (Cell Line: HS 578T) [3]
Indazole derivative 5 + Amonafide DCOF7D1 Indazole derivative 5 Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Indazole derivative 5 + Amonafide DCRYF8A Indazole derivative 5 Astrocytoma (Cell Line: SNB-19) [2]
Lenalidomide + Amonafide DCB9JJ9 Lenalidomide Clear cell renal cell carcinoma (Cell Line: TK-10) [2]
Raloxifene + Amonafide DC0O9B6 Raloxifene Chronic myelogenous leukemia (Cell Line: K-562) [2]
Raloxifene + Amonafide DCWDGT5 Raloxifene Renal cell carcinoma (Cell Line: SN12C) [2]
Ruxolitinib + Amonafide DCGNAYU Ruxolitinib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Ruxolitinib + Amonafide DCTUOO4 Ruxolitinib Clear cell renal cell carcinoma (Cell Line: A498) [2]
Ruxolitinib + Amonafide DCG7ZW4 Ruxolitinib Clear cell renal cell carcinoma (Cell Line: 786-0) [2]
Trifluridine + Amonafide DC1I83B Trifluridine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
Trifluridine + Amonafide DCGTZSX Trifluridine Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
Trifluridine + Amonafide DCUIT46 Trifluridine Colon carcinoma (Cell Line: KM12) [3]
Trifluridine + Amonafide DCRA8JJ Trifluridine Lung adenocarcinoma (Cell Line: HOP-62) [4]
Trifluridine + Amonafide DC2MBPY Trifluridine Malignant melanoma (Cell Line: LOX IMVI) [4]
Vandetanib + Amonafide DCTMZSR Vandetanib Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
Vandetanib + Amonafide DCWFSCN Vandetanib Adenocarcinoma (Cell Line: HCT-15) [4]
Vandetanib + Amonafide DCUDB8C Vandetanib Clear cell renal cell carcinoma (Cell Line: 786-0) [4]
Vandetanib + Amonafide DCYXNG2 Vandetanib Clear cell renal cell carcinoma (Cell Line: CAKI-1) [4]
Vandetanib + Amonafide DCJOUIH Vandetanib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [4]
Vandetanib + Amonafide DCYT4XJ Vandetanib Lung adenocarcinoma (Cell Line: MDA-MB-231) [4]
Vemurafenib + Amonafide DCCYNHW Vemurafenib Colon adenocarcinoma (Cell Line: COLO 205) [3]
Vemurafenib + Amonafide DCI0LLP Vemurafenib Clear cell renal cell carcinoma (Cell Line: 786-0) [4]
Vemurafenib + Amonafide DCAJXYV Vemurafenib Clear cell renal cell carcinoma (Cell Line: CAKI-1) [4]
Vemurafenib + Amonafide DCU6020 Vemurafenib Cutaneous melanoma (Cell Line: SK-MEL-5) [4]
Vemurafenib + Amonafide DCSMEQH Vemurafenib Malignant melanoma (Cell Line: LOX IMVI) [4]
Vemurafenib + Amonafide DC3WVTI Vemurafenib Melanoma (Cell Line: UACC-257) [4]
Vemurafenib + Amonafide DCIBUAX Vemurafenib Melanoma (Cell Line: MALME-3M) [4]
Vismodegib + Amonafide DCO626A Vismodegib Clear cell renal cell carcinoma (Cell Line: 786-0) [4]
Vismodegib + Amonafide DCT9CQ4 Vismodegib Renal cell carcinoma (Cell Line: UO-31) [4]
------------------------------------------------------------------------------------
⏷ Show the Full List of 636 DrugCom(s)

References

1 ClinicalTrials.gov (NCT00715637) Phase III Randomized Study of Amonafide (AS1413) and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary Acute Myeloid Leukemia (AML)- the ACCEDEStudy. U.S. National Institutes of Health.
2 Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension.Hepatology. 2016 Jun;63(6):1977-86. doi: 10.1002/hep.28499. Epub 2016 Mar 31.
3 Biologically active neutrophil chemokine pattern in tonsillitis.Clin Exp Immunol. 2004 Mar;135(3):511-8. doi: 10.1111/j.1365-2249.2003.02390.x.
4 Loss of function mutations in VARS encoding cytoplasmic valyl-tRNA synthetase cause microcephaly, seizures, and progressive cerebral atrophy.Hum Genet. 2018 Apr;137(4):293-303. doi: 10.1007/s00439-018-1882-3. Epub 2018 Apr 24.